Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|September 7, 2010
Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinibPaul W Manley, Nikolaus Stiefl, Sandra W Cowan-Jacob, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 17, 2010
Constriction of rat extra-splenic veins to lipopolysaccharide involves endothelin-1Arnaud Mansart, Lewis J Ruff, Mark P Ariaans, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Identification and structure-activity relationship of 2-morpholino 6-(3-hydroxyphenyl) pyrimidines, a class of potent and selective PI3 kinase inhibitorsSabina Pecchi, Paul A Renhowe, Clarke Taylor, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2006
Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studiesXiaodong Lin, Jeremy M Murray, Alice C Rico, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2013
Structure guided optimization of a fragment hit to imidazopyridine inhibitors of PI3KSabina Pecchi, Zhi-Jie Ni, Wooseok Han, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2016
Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft modelWooseok Han, Daniel L Menezes, Yongjin Xu, et al.
Cancer Research|August 19, 2017
Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate CancerLingyan Jin, Jesse Garcia, Emily Chan, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Identification of BRaf-Sparing Amino-Thienopyrimidines with Potent IRE1α Inhibitory ActivityRamsay E Beveridge, Heidi Ackerly Wallweber, Avi Ashkenazi, et al.
Pageof 6